Despite these similarities, there is variability in chemoattractant secretion such as CCL2 and a number of other pro-inflammatory cytokines including tumour necrosis factor-α (TNF-α) across different AD patient origins [24–30]. Here, CCL2 is linked to Alzheimer disease.